Literature DB >> 20237198

Identification of cytokines in whole blood for differential diagnosis of tuberculosis versus pneumonia.

Wen-Lin Su1, Wann-Cherng Perng, Ching-Hui Huang, Cheng-Yu Yang, Chin-Pyng Wu, Feng-Yee Chang, Jenn-Han Chen.   

Abstract

Differentiating tuberculosis (TB) from pneumonia remains a challenge. We evaluated the cytokine profiles of whole blood cells from patients with TB (n = 38) or pneumonia (n = 30) and from healthy individuals (n = 30) before and after stimulating cells with ESAT-6 or lipopolysaccharide (LPS). When the percent change in the levels of gamma interferon (IFN-gamma) after stimulation with ESAT-6 was used in receiver operating characteristics (ROC) analysis (a graphic method to determine the diagnostic accuracy of a test) to identify a patient with TB, the area under the curve (AUC) was 90.4%, and a cutoff point of a 3.59% change produced a corresponding sensitivity, specificity, and accuracy of over 80%. When the change in IFN-gamma after stimulation of blood cells with LPS was used to identify a patient with pneumonia, the AUC reached 89.1%, and a cutoff point of 3.59% produced a sensitivity, specificity, and accuracy of approximately 80% each. When the change in interleukin-12 (IL-12) after stimulation of blood cells with LPS was selected to define a patient with pneumonia, the AUC was 85.2%, and a cutoff point of 2.08% gave a sensitivity, specificity, and accuracy of 80.0%, 78.9%, and 79.4%, respectively. We conclude that the percent change in IFN-gamma after stimulation of whole blood cells with ESAT-6 may differentiate patients with TB from patients with pneumonia. The percent change in IFN-gamma and IL-12 after LPS stimulation of whole blood cells could differentiate patients with pneumonia from patients with TB.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20237198      PMCID: PMC2863376          DOI: 10.1128/CVI.00526-09

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  26 in total

Review 1.  Immunity to tuberculosis: a delicate balance between protection and pathology.

Authors:  S Ehlers
Journal:  FEMS Immunol Med Microbiol       Date:  1999-02

2.  Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.

Authors:  Lionel A Mandell; Richard G Wunderink; Antonio Anzueto; John G Bartlett; G Douglas Campbell; Nathan C Dean; Scott F Dowell; Thomas M File; Daniel M Musher; Michael S Niederman; Antonio Torres; Cynthia G Whitney
Journal:  Clin Infect Dis       Date:  2007-03-01       Impact factor: 9.079

3.  Multicenter evaluation of the BACTEC MGIT 960 system for recovery of mycobacteria.

Authors:  B A Hanna; A Ebrahimzadeh; L B Elliott; M A Morgan; S M Novak; S Rusch-Gerdes; M Acio; D F Dunbar; T M Holmes; C H Rexer; C Savthyakumar; A M Vannier
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

Review 4.  Monocyte chemoattractant protein-1 (CCL2) in inflammatory disease and adaptive immunity: therapeutic opportunities and controversies.

Authors:  Christine Daly; Barrett J Rollins
Journal:  Microcirculation       Date:  2003-06       Impact factor: 2.628

5.  Usefulness of the QuantiFERON TB-2G test for the differential diagnosis of pulmonary tuberculosis.

Authors:  Yoshihiro Kobashi; Keiji Mouri; Shinichi Yagi; Yasushi Obase; Minoru Fukuda; Naoyuki Miyashita; Mikio Oka
Journal:  Intern Med       Date:  2008-02-15       Impact factor: 1.271

6.  Detection of Mycobacterium tuberculosis by real-time PCR using pan-mycobacterial primers and a pair of fluorescence resonance energy transfer probes specific for the M. tuberculosis complex.

Authors:  Christian Drosten; Marcus Panning; Stefanie Kramme
Journal:  Clin Chem       Date:  2003-10       Impact factor: 8.327

7.  Sputum cytokine levels in patients with pulmonary tuberculosis as early markers of mycobacterial clearance.

Authors:  Rodrigo Ribeiro-Rodrigues; Tatiana Resende Co; John L Johnson; Fabiola Ribeiro; Moises Palaci; Ricardo T Sá; Ethel L Maciel; Fausto E Pereira Lima; Valderio Dettoni; Zahra Toossi; W Henry Boom; Reynaldo Dietze; Jerrold J Ellner; Christina S Hirsch
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

8.  Differential diagnosis of tuberculous pleurisy by measurement of cytokine concentrations in pleural effusion.

Authors:  K Ogawa; H Koga; Y Hirakata; K Tomono; T Tashiro; S Kohno
Journal:  Tuber Lung Dis       Date:  1997

9.  The differential diagnostic values of cytokine levels in pleural effusions.

Authors:  Saadet Akarsu; A Nese Citak Kurt; Yasar Dogan; Erdal Yilmaz; Ahmet Godekmerdan; A Denizmen Aygun
Journal:  Mediators Inflamm       Date:  2005-02-24       Impact factor: 4.711

10.  IP-10, MCP-1, MCP-2, MCP-3, and IL-1RA hold promise as biomarkers for infection with M. tuberculosis in a whole blood based T-cell assay.

Authors:  Morten Ruhwald; Morten Bjerregaard-Andersen; Paulo Rabna; Jesper Eugen-Olsen; Pernille Ravn
Journal:  BMC Res Notes       Date:  2009-02-04
View more
  4 in total

1.  Discrimination between active and latent tuberculosis based on ratio of antigen-specific to mitogen-induced IP-10 production.

Authors:  Yun Hee Jeong; Yun-Gyoung Hur; Hyejon Lee; Sunghyun Kim; Jang-Eun Cho; Jun Chang; Sung Jae Shin; Hyeyoung Lee; Young Ae Kang; Sang-Nae Cho; Sang-Jun Ha
Journal:  J Clin Microbiol       Date:  2014-11-26       Impact factor: 5.948

2.  Potential of host markers produced by infection phase-dependent antigen-stimulated cells for the diagnosis of tuberculosis in a highly endemic area.

Authors:  Novel N Chegou; Paulin N Essone; Andre G Loxton; Kim Stanley; Gillian F Black; Gian D van der Spuy; Paul D van Helden; Kees L Franken; Shreemanta K Parida; Michel R Klein; Stefan H E Kaufmann; Tom H M Ottenhoff; Gerhard Walzl
Journal:  PLoS One       Date:  2012-06-05       Impact factor: 3.240

Review 3.  Cytokines as Biomarkers and Their Respective Clinical Cutoff Levels.

Authors:  Rebecca N Monastero; Srinivas Pentyala
Journal:  Int J Inflam       Date:  2017-04-09

4.  Utility of host markers detected in Quantiferon supernatants for the diagnosis of tuberculosis in children in a high-burden setting.

Authors:  Novel N Chegou; Anne K Detjen; Lani Thiart; Elisabetta Walters; Anna M Mandalakas; Anneke C Hesseling; Gerhard Walzl
Journal:  PLoS One       Date:  2013-05-15       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.